JP Morgan Chase
QTTB icon

JP Morgan Chase’s Q32 Bio QTTB Stock Holding History

JP Morgan Chase’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-324
Closed -$1.08K – 7971
2025
Q4 		$1.08K Buy
324
+320
+8,000% +$904 ﹤0.01% 7017
2025
Q3 		$8 Buy
+4
New +$8 ﹤0.01% 7327
2025
Q2 		– Sell
-2,930
Closed -$4.83K – 7748
2025
Q1 		$4.83K Buy
2,930
+99
+3% +$267 ﹤0.01% 6438
2024
Q4 		$9.74K Sell
2,831
-857
-23% -$27.1K ﹤0.01% 6395
2024
Q3 		$165K Buy
3,688
+1,068
+41% +$39.2K ﹤0.01% 5495
2024
Q2 		$47K Buy
2,620
+2,569
+5,037% +$61.5K ﹤0.01% 5884
2024
Q1 		$869 Sell
51
-2
-4% -$28 ﹤0.01% 6659
2023
Q4 		$580 Hold
53
– – ﹤0.01% 6909
2023
Q3 		$1.12K Hold
53
– – ﹤0.01% 6628
2023
Q2 		$844 Sell
53
-22,910
-100% -$411K ﹤0.01% 6478
2023
Q1 		$426K Hold
22,963
– – ﹤0.01% 4604
2022
Q4 		$521K Sell
22,963
-129
-0.6% -$3.42K ﹤0.01% 4479
2022
Q3 		$669K Sell
23,092
-16,350
-41% -$667K ﹤0.01% 4273
2022
Q2 		$1.4M Sell
39,442
-1,271
-3% -$43.4K ﹤0.01% 3839
2022
Q1 		$2.23M Sell
40,713
-3,024
-7% -$188K ﹤0.01% 3661
2021
Q4 		$2.87M Sell
43,737
-20,524
-32% -$1.99M ﹤0.01% 3544
2021
Q3 		$9.1M Buy
64,261
+1,955
+3% +$249K ﹤0.01% 2468
2021
Q2 		$8.15M Sell
62,306
-60,320
-49% -$7.53M ﹤0.01% 2606
2021
Q1 		$20.8M Sell
122,626
-68,580
-36% -$14.4M ﹤0.01% 1735
2020
Q4 		$38.9M Buy
191,206
+27,367
+17% +$5.29M 0.01% 1196
2020
Q3 		$31.3M Buy
163,839
+9,930
+6% +$2.23M 0.01% 1215
2020
Q2 		$42.1M Buy
153,909
+25,919
+20% +$6.91M 0.01% 973
2020
Q1 		$35.8M Buy
127,990
+4,432
+4% +$1.36M 0.01% 942
2019
Q4 		$46M Buy
123,558
+4,871
+4% +$1.4M 0.01% 1012
2019
Q3 		$38.7M Buy
118,687
+7,205
+6% +$2.45M 0.01% 1092
2019
Q2 		$38.7M Buy
111,482
+1,406
+1% +$553K 0.01% 1108
2019
Q1 		$54.9M Sell
110,076
-13,773
-11% -$6.16M 0.01% 903
2018
Q4 		$49.8M Sell
123,849
-1,231
-1% -$466K 0.01% 900
2018
Q3 		$51.5M Buy
125,080
+28,675
+30% +$9.74M 0.01% 1001
2018
Q2 		$35.4M Buy
96,405
+28,749
+42% +$10.3M 0.01% 1178
2018
Q1 		$22.8M Buy
+67,656
New +$22.7M ﹤0.01% 1420

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase's QTTB Position: Q1 2026 in Review

JP Morgan Chase sold out of Q32 Bio (QTTB) in Q1 2026, closing a stake of 324 shares — an estimated $1.08K sold.

JP Morgan Chase first reported a position in QTTB in Q1 2018 and held it in 31 quarters. The position peaked at $54.9M in Q1 2019. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • JP Morgan Chase reported no remaining Q32 Bio position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 324 Q32 Bio shares in Q1 2026, an estimated $1.08K.
  • JP Morgan Chase first reported a position in Q32 Bio in Q1 2018 and held it in 31 quarters.
  • JP Morgan Chase's Q32 Bio position peaked at $54.9M in Q1 2019.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.